12:00-1:45pm. China faces many challenges in its healthcare policies. An ageing population accounts for 10% of people over 65. A growing middle class has increased expectation for quality and diversity of healthcare options. The public hospital system is straining from overload. The State Council ranks public hospital reform as its top priority.
The opportunities arising from these challenges are many. Foreign investment is broadly permitted, and often encouraged. If direct ownership is not desirable, the desire for expertise in hospital management has opened the market for entrusted management arrangements. There is a coming diversification of revenue away from mark-up on medication, to service-based fees, which will gather pace as the medical insurance market opens.
No reward comes without risk… and there are risks aplenty. The regulatory climate is still uncertain. There are institutional challenges to overcome to transform bureaucratic governance to efficient patient service delivery. The horizon for greenfield investments is long-term, and beyond the usual term for private equity investments. Nonetheless, there are few sectors that hold a brighter outcome in the risk/reward matrix than healthcare in China. Our session will provide a 360° view of: The current investment landscape The available investment options and transaction structures The regulatory environment The identification and treatment of risks
First 15-20 minutes is for networking Sandwiches & beverages included
Hosted by the Insurance & Healthcare Committee
The American Chamber of Commerce in HK 1904 Bank of America Tower 12 Harcourt Road Central, Hong Kong